Published online February 5, 2007
doi:10.1084/jem.20061916
The Journal of Experimental Medicine, Vol. 204, No. 2, 405-420
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Behfar et al.
Cardiopoietic programming of embryonic stem cells for tumor-free heart repair
Atta Behfar,
Carmen Perez-Terzic,
Randolph S. Faustino,
D. Kent Arrell,
Denice M. Hodgson,
Satsuki Yamada,
Michel Puceat,
Nicolas Niederländer,
Alexey E Alekseev,
Leonid V. Zingman, and
Andre Terzic
Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Department of Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Department of Medical Genetics, and Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN 55905
CORRESPONDENCE Andre Terzic: terzic.andre{at}mayo.edu
Embryonic stem cells have the distinct potential for tissue regeneration, including cardiac repair. Their propensity for multilineage differentiation carries, however, the liability of neoplastic growth, impeding therapeutic application. Here, the tumorigenic threat associated with embryonic stem cell transplantation was suppressed by cardiac-restricted transgenic expression of the reprogramming cytokine TNF-
, enhancing the cardiogenic competence of recipient heart. The in vivo aptitude of TNF-
to promote cardiac differentiation was recapitulated in embryoid bodies in vitro. The procardiogenic action required an intact endoderm and was mediated by secreted cardio-inductive signals. Resolved TNF-
induced endoderm-derived factors, combined in a cocktail, secured guided differentiation of embryonic stem cells in monolayers produce cardiac progenitors termed cardiopoietic cells. Characterized by a down-regulation of oncogenic markers, up-regulation, and nuclear translocation of cardiac transcription factors, this predetermined population yielded functional cardiomyocyte progeny. Recruited cardiopoietic cells delivered in infarcted hearts generated cardiomyocytes that proliferated into scar tissue, integrating with host myocardium for tumor-free repair. Thus, cardiopoietic programming establishes a strategy to hone stem cell pluripotency, offering a tumor-resistant approach for regeneration.
Abbreviations used: BMP, bone morphogenetic protein; CFP, cyan fluorescence protein; EGF, epidermal growth factor; FGF, fibroblast growth factor; IGF, insulin-like growth factor; MAPK, mitogen-activated protein kinase; MEF, myocyte enhancer factor; NGF, nerve growth factor; TACE, TNF-
converting enzyme; TAK, TGF-ßactivated kinase; VEGF, vascular endothelial growth factor.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Related Article
-
Tumor-free heart repair
- Hema Bashyam
J. Exp. Med. 2007 204: 208a.
[Full Text]
[PDF]
This article has been cited by other articles:
-
Nelson, T. J., Faustino, R. S., Chiriac, A., Crespo-Diaz, R., Behfar, A., Terzic, A.
(2008). CXCR4+/FLK-1+ Biomarkers Select a Cardiopoietic Lineage from Embryonic Stem Cells. Stem Cells
26: 1464-1473
[Abstract]
[Full Text]
-
Schenke-Layland, K., Rhodes, K. E., Angelis, E., Butylkova, Y., Heydarkhan-Hagvall, S., Gekas, C., Zhang, R., Goldhaber, J. I., Mikkola, H. K., Plath, K., MacLellan, W. R.
(2008). Reprogrammed Mouse Fibroblasts Differentiate into Cells of the Cardiovascular and Hematopoietic Lineages. Stem Cells
26: 1537-1546
[Abstract]
[Full Text]
-
Smart, N., Riley, P. R.
(2008). The Stem Cell Movement. Circ. Res.
102: 1155-1168
[Abstract]
[Full Text]
-
Crisostomo, P. R., Wang, Y., Markel, T. A., Wang, M., Lahm, T., Meldrum, D. R.
(2008). Human mesenchymal stem cells stimulated by TNF-{alpha}, LPS, or hypoxia produce growth factors by an NF{kappa}B- but not JNK-dependent mechanism. Am. J. Physiol. Cell Physiol.
294: C675-C682
[Abstract]
[Full Text]
-
Arrell, D. K., Niederlander, N. J., Faustino, R. S., Behfar, A., Terzic, A.
(2008). Cardioinductive Network Guiding Stem Cell Differentiation Revealed by Proteomic Cartography of Tumor Necrosis Factor {alpha}-Primed Endodermal Secretome. Stem Cells
26: 387-400
[Abstract]
[Full Text]
-
Behfar, A., Terzic, A.
(2007). Cardioprotective repair through stem cell-based cardiopoiesis. J. Appl. Physiol.
103: 1438-1440
[Abstract]
[Full Text]
-
Janssens, S.
(2007). Human embryonic stem cells for cardiac repair: the focus is on refined selection and cardiopoietic programming. Heart
93: 1173-1174
[Full Text]
-
Tomescot, A., Leschik, J., Bellamy, V., Dubois, G., Messas, E., Bruneval, P., Desnos, M., Hagege, A. A., Amit, M., Itskovitz, J., Menasche, P., Puceat, M.
(2007). Differentiation In Vivo of Cardiac Committed Human Embryonic Stem Cells in Postmyocardial Infarcted Rats. Stem Cells
25: 2200-2205
[Abstract]
[Full Text]